Fig. 11From: Exploring the active components and potential mechanisms of Rosa roxburghii Tratt in treating type 2 diabetes mellitus based on UPLC-Q-exactive Orbitrap/MS and network pharmacologyVisualization of molecular docking of the key target active ingredient. Green represents the receptor proteins, yellow represents the ligand compounds, and the label is the binding site and the distanceBack to article page